Silo Pharma Secures Global License for Alzheimer's Drug -- Shares Surge-February 2024-www.financetom.com

Silo Pharma Secures Global License for Alzheimer's Drug -- Shares Surge

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Silo Pharma Secures Global License for Alzheimer's Drug -- Shares Surge

Jul 16, 2024 4:39 AM

07:23 AM EDT, 07/16/2024 (MT Newswires) -- Silo Pharma ( SILO ) said Tuesday that it has entered into an exclusive global license agreement to further develop, manufacture, and commercialize its Alzheimer's drug, SPC-14.

Silo said it plans to leverage the US Food and Drug Administration's expedited 505(b)(2) pathway for SPC-14 to shorten clinical timelines and lower drug development expenses.

Shares of the company were up 97% in recent Tuesday premarket trading.

Price: 2.1100, Change: +1.04, Percent Change: +97.20

Previous page： Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows Next page： Texas Pacific Land Insider Bought Shares Worth $459,482, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows

Mar 6, 2024

ViiV Healthcare, majority owned by GSK Plc ( GSK ) , with Pfizer Inc ( PFE ) and Shionogi Limited as shareholders, revealed data from a planned interim analysis of the LATITUDE phase 3 trial. The data indicated that long-acting injectable antiretroviral treatment (ART) for HIV, Cabenuva (cabotegravir + rilpivirine), demonstrated superior efficacy in maintaining viral load suppression compared to daily oral therapy in individuals with a history of...

Texas Pacific Land Insider Bought Shares Worth $459,482, According to a Recent SEC Filing

Mar 6, 2024

05:03 PM EST, 03/06/2024 (MT Newswires) -- Eric L Oliver, Director, on March 04, 2024, executed a purchase for 300 shares in Texas Pacific Land ( TPL ) for $459,482. Following the Form 4 filing with the SEC, Oliver has control over a total of 133,719 shares of the company, with 319 shares held directly and 133,400 controlled indirectly. SEC...

Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement

Mar 6, 2024

Emergent Biosolutions Inc ( EBS ) shares are trading higher after the company amended its existing credit agreement and reported its fourth-quarter financial results. Here's a look at the details. The Details: Emergent BioSolutions ( EBS ) reported quarterly losses of 77 cents per share, missing the analyst consensus estimate of losses of 19 cents per share. Quarterly sales came...

Five9 Insider Sold Shares Worth $2,715,680, According to a Recent SEC Filing

Mar 6, 2024

05:02 PM EST, 03/06/2024 (MT Newswires) -- Michael Burkland, Chief Executive Officer, on March 04, 2024, sold 46,447 shares in Five9 ( FIVN ) for $2,715,680. Following the Form 4 filing with the SEC, Burkland has control over a total of 411,495 shares of the company, with 278,469 shares held directly and 133,026 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1288847/000128884724000020/xslF345X03/wk-form4_1709762280.xml ...